ArticleJournal, genetic engineering & biotechnology2022

The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients.

Eman Abd El Razek Abbas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.